NRx shares jump 39% on new clinical data testing its experimental COVID-19 drug in the critically ill

NRx shares jump 39% on new clinical data testing its experimental COVID-19 drug in the critically ill
·1 min read

Shares of NRx Pharmaceuticals Inc. soared 39.9% in premarket trading on Thursday after the company said new

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting